Luminex Corporation to Feature ARIES System and NxTAG Respiratory Pathogen Panel at AMP Annual Meeting


Recently cleared products will be highlighted at workshops, product demonstrations, events, and posters



AUSTIN, Texas - Luminex Corporation (NASDAQ: LMNX) today announced that it will be featuring the newly FDA-cleared ARIES® System and recently CE-marked NxTAG® Respiratory Pathogen Panel at the Association for Molecular Pathology (AMP) Annual Meeting occurring November 5 to 7, 2015 in Austin, Texas.



About ARIES®

ARIES® is a sample to answer system crafted to increase laboratory efficiency, produce accurate results, and fit seamlessly into today's lean laboratory environment. The ARIES® System uses internal barcode scanning and other advanced features to minimize operator errors. Two independent modules each support from one to six cassettes, allowing for both STAT and Batch testing. IVD and MultiCode® Analyte Specific Reagents can be run simultaneously when using a common Universal Assay Protocol. An integrated touchscreen PC eliminates the need for a separate computer, stand-alone keyboard, and mouse; thus maximizing valuable bench space.



ARIES at AMP



    --  Workshop: "Welcome to the New Way to Work: ARIES®, the Next Generation

        of Sample to Answer Testing," on Wednesday, November 4, 2015 at 9 am in

        Room 12B, Level 4. Stephen Young, PhD, D(ABMM), Scientific

        Director-Infectious Disease, TriCore Reference Laboratories, will

        present performance characteristics of ARIES® HSV 12 Assay based on

        the clinical trial data generated at TriCore and share the ARIES work

        experience at his laboratory.

    --  Poster: "Improved Laboratory Workflow with ARIES®--A Time and Motion

        Study" (S. Dunbar/Luminex).

    --  ARIES® Introduction: Thursday, November 5 at 3 pm at Booth #911:

        Luminex will officially mark the launch of ARIES® with remarks by

        customers in the early access program.



About NxTAG

NxTAG Respiratory Pathogen Panel is CE-marked in Europe, and available for Research Use Only (RUO) in the U.S. NxTAG Respiratory Pathogen Panel is an assay that detects relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila. The panel is the only respiratory assay that enables laboratories to easily and simultaneously detect these respiratory pathogens in a single, closed tube system and in a format that scales to accommodate changes in throughput needed to respond to seasonal changes in demand, especially during flu season. NxTAG Respiratory Pathogen Panel requires only minutes of hands-on time with no upstream reagent preparation. The innovative tube strip design offers laboratories the flexibility to process a single sample or up to 96 samples per run, without wasting consumables or reagents. Total turnaround time is only about three hours for 96 samples (excluding extraction).



NxTAG at AMP



    --  Workshop:"NxTAG Respiratory Pathogen Panel (RUO)*--The New Paradigm in

        Molecular Respiratory Disease Testing," Wednesday, November 4, 2015 at 3

        pm in Room 12B, Level 4. Dr. Catherine Moore from Public Health Wales

        will describe a prospective study to determine baseline respiratory

        pathogen levels in sudden death cases. In combination with culture and

        histology, the NxTAG Respiratory Pathogen Panel (RUO) revealed that

        respiratory viruses are frequently detected in the respiratory tracts of

        these individuals, and especially in infants. Dr. Arundhati Rao from

        Scott White Memorial Hospital will present results of the NxTAG

        clinical study conducted at her laboratory and share some insights from

        a time and motion study comparing NxTAG to other molecular respiratory

        disease assays.

    --  Posters: "Automation of the Luminex NxTAG Respiratory Pathogen Panel

        (RUO)" (M. Phillips/Luminex); "Assessment of a High Throughput Next

        Generation Multiplex Respiratory Pathogen Panel" (J.H. Chen/Queen Mary

        Hospital, Hong Kong; LMD); "Workflow Evaluation of the Luminex NxTAG

        Respiratory Pathogen Panel (RUO)" (K. Post/IU Health).



AMP Events Sponsored by Luminex



    --  International Showcase Event, Wednesday, November 4, 2015 at 7 pm. This

        event will feature selected case study presentations on international

        collaborations with members outside the U.S. and updates on the

        initiatives of the International Affairs Committee and AMP's

        international affiliates.

    --  Science Educator Workshop, Wednesday, November 4, 2015 from 7:30 am-3:35

        pm. AMP will be hosting a complimentary workshop for Austin area

        educators at local high schools and colleges. The goal is to introduce

        molecular diagnostics as a valuable and in-demand field of study to

        these science teachers.



About Luminex Corporation

Luminex is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life science companies. Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research, and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.



Contacts:

Luminex Media Contact

Christine Valle, 512-219-8020

Sr. Manager, Global Marketing

cvalle@luminexcorp.com



Additional Media Contact

Nicole Litchfield, 415-793-6468

nicole@bioscribe.com



*For Research Use Only. Not for use in diagnostic procedures.



Source 

Luminex Corporation



Web Site: http://www.luminexcorp.com

More from Packaging Products & Equipment

All Topics